Evolus Inc [EOLS] stock is trading at $10.24, up 3.75%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The EOLS shares have gain 4.49% over the last week, with a monthly amount glided 2.61%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Evolus Inc [NASDAQ: EOLS] stock has seen the most recent analyst activity on April 17, 2025, when BTIG Research initiated its Buy rating and assigned the stock a price target of $21. Previously, Barclays upgraded its rating to Overweight on January 29, 2024, and elevated its price target to $16. On June 23, 2022, Needham initiated with a Buy rating and assigned a price target of $18 on the stock. Barclays upgraded its rating to a Equal Weight and increased its price target to $10 on May 12, 2022. Truist upgraded its rating to a Buy but $11 remained the price target by the analyst firm on January 20, 2022. Mizuho upgraded its rating to Buy for this stock on May 06, 2021, but kept the price target unchanged to $15. In a note dated April 08, 2021, H.C. Wainwright reiterated an Buy rating on this stock and boosted its target price from $20 to $22.
Evolus Inc [EOLS] stock has fluctuated between $8.67 and $17.82 over the past year. Currently, Wall Street analysts expect the stock to reach $24 within the next 12 months. Evolus Inc [NASDAQ: EOLS] shares were valued at $10.24 at the most recent close of the market. An investor can expect a potential return of 134.38% based on the average EOLS price forecast.
Analyzing the EOLS fundamentals
Evolus Inc [NASDAQ:EOLS] reported sales of 275.46M for the trailing twelve months, which represents a growth of 15.49%. Gross Profit Margin for this corporation currently stands at 0.68% with Operating Profit Margin at -0.14%, Pretax Profit Margin comes in at -0.2%, and Net Profit Margin reading is -0.2%. To continue investigating profitability, this company’s Return on Assets is posted at -0.26, Equity is -9.32 and Total Capital is -0.25. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -1.27.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 9.99 points at the first support level, and at 9.75 for the second support level. However, for the 1st resistance point, the stock is sitting at 10.55, and for the 2nd resistance point, it is at 10.87.
Ratios To Look Out For
For context, Evolus Inc’s Current Ratio is 2.34. As well, the Quick Ratio is 2.16, while the Cash Ratio is 1.21. Considering the valuation of this stock, the price to sales ratio is 2.40.
Transactions by insiders
Recent insider trading involved White Albert G III, Director, that happened on Jun 09 ’25 when 20000.0 shares were purchased., Avelar Rui completed a deal on May 12 ’25 to sell 3385.0 shares. Meanwhile, Chief Financial Officer Beaver Sandra sold 6494.0 shares on May 13 ’25.
